Investor Relations

Print page     Email page

Myrexis, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel therapies for the treatment of cancer. Our pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures that have the potential to be first-in-class and/or best-in-class therapeutics.

Recent Releases Sep 2, 2010 Myrexis to Present at Rodman & Renshaw and UBS Conferences Aug 31, 2010 Myrexis to Hold Conference Call to Discuss Fiscal Year 2010 Results View all releases » Events & Presentations Sep 9, 2010 at 4:30 PM ET Myrexis Fourth Quarter FY 2010 Conference Call View all events & presentations »

Stock Chart 3 Mo.   6 Mo.   1 Yr. Stock Quote Myrexis, Inc. Price: 3.81 Change: 0.01 Day High: 3.85 Day Low: 3.73 Volume: 105,900 Delayed at least 20 minutes. Provided by eSignal.